The survival analysis, median GBP1 expression of 1.8 in 150 patients with BC, showed that elevations in GBP1 expression results in shorter survival compared to low-level expression of GBP1 (χ2=3.204, P<0.001; Fig.2). This evidence concerns the gene GBP1 and breast cancer.